1. Home
  2. INDI vs KURA Comparison

INDI vs KURA Comparison

Compare INDI & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo indie Semiconductor Inc.

INDI

indie Semiconductor Inc.

HOLD

Current Price

$3.48

Market Cap

750.1M

Sector

Technology

ML Signal

HOLD

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$9.36

Market Cap

841.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDI
KURA
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
750.1M
841.6M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
INDI
KURA
Price
$3.48
$9.36
Analyst Decision
Strong Buy
Buy
Analyst Count
4
11
Target Price
$6.25
$25.56
AVG Volume (30 Days)
4.8M
1.2M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
3.95
N/A
EPS
N/A
N/A
Revenue
$217,394,000.00
$67,482,000.00
Revenue This Year
$25.54
$28.28
Revenue Next Year
$38.45
$106.37
P/E Ratio
N/A
N/A
Revenue Growth
0.33
25.24
52 Week Low
$2.32
$5.45
52 Week High
$6.05
$12.49

Technical Indicators

Market Signals
Indicator
INDI
KURA
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
INDI
KURA

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc caters to the autotech industry with semiconductors, photonics, and software platforms. The company's products include devices for a multitude of automotive applications spanning vision and radar processors, in-cabin wireless charging and USB power delivery, device interfacing through Apple CarPlay and Android Auto, and high-speed video and data connectivity. New products under evaluation or development include LiDAR, cybersecurity-enabled microcontrollers, and sensor-fusion processors. Its Photonics division mainly offers low-noise lasers, standard, and custom light sources. Geographically, the company generates the majority of its revenue from Greater China and the rest from the United States, Europe, South Korea, and other regions.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Share on Social Networks: